High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$9.9M
$9,894,759
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2026-03-13 | $547,842 | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2026-03-13 | $1,209,072Large | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2026-03-13 | $6,210 | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-10-09 | $2,055,625Large | M | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-10-09 | $2,950,654Large | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-10-09 | $78,682 | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-10-02 | $57,355 | M | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-10-02 | $91,506 | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-10-01 | $1,931,116Large | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-10-01 | $1,360,760Large | M | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-09-30 | $291,203 | M | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-09-30 | $414,371 | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-09-29 | $346,306 | M | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-09-29 | $491,485 | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-09-23 | $1,393,899Large | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-09-23 | $622,261 | M | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
10b5-1 Sell
|
2025-09-22 | $779,921 | S | Form 4 |
| SUPN |
SUPERNUS PHARMACEUTICALS, INC.
|
CEO
Other
|
2025-09-22 | $351,239 | M | Form 4 |